We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Researchers Discover New Vulnerability in Deadly Form of Lung Cancer

Video   Jul 04, 2018 | UT Southwestern, YouTube

 

Researchers at the Children’s Medical Center Research Institute at UT Southwestern (CRI) have discovered a new metabolic vulnerability in small cell lung cancer (SCLC) that can be targeted by existing drug therapies.

SCLC is a deadly and aggressive form of lung cancer with few therapeutic options and an incredibly low five-year survival rate of 5 percent. Researchers at CRI believe the key to finding new therapies for this disease lies in better understanding the metabolism of SCLC.

This content has been republished from materials provided by UT Southwestern. Note: material may have been edited for length and content. For further information, please contact the cited source.

 
More Information
 
 
Advertisement
 

Recommended Videos

Teach Me in 10 - CRISPR, Cell Therapies and Drug Discovery With Dr Theo Roth

Video

This instalment of Teach Me in 10 features Dr Theo Roth, whose work bridges a number of different fields, such as genome engineering, cancer immunology and cell-based therapies.

WATCH NOW

First Volunteers Receive Imperial COVID-19 Vaccine

Video

The first healthy volunteers have now received a candidate coronavirus vaccine developed by Imperial researchers.

WATCH NOW

Can Steroids Save Your Life?

Video

Explore the science of how corticosteroids sneak into our cells to help fight allergic reactions, rashes, asthma, and harmful immune responses.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE